论文部分内容阅读
目的： 探讨施瑞癌症快速尿检试剂的应用价值。方法： 应用施瑞癌症快速尿检试剂， 对１２４８ 份尿样进行检测，并对该方法作出评估。结果： 该尿检试剂对多种肿瘤敏感，具有广谱性，恶性肿瘤阳性率（７６ ．３６ ％ ） 显著高于正常人群（１ ．６６ ％ ） 及良性肿瘤（６ ．２５ ％ ） 。结论：施瑞癌症快速尿检对恶性肿瘤的早期筛查具有一定的价值。
Objective: To explore the application value of Shi Rui cancer rapid urine test reagent. METHODS: 1248 urine samples were tested using the SYR cancer rapid urine test reagent and evaluated. Results: The urine test reagent was sensitive to many kinds of tumors and had a broad spectrum. The positive rate of malignant tumors (76.36%) was significantly higher than that of the normal population (1.66%) and benign tumors (6.25%). CONCLUSIONS: The rapid urine test for cancer in Swiss Cancer has certain value for the early screening of malignant tumors.